Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.
about
Device-based Therapy for HypertensionCentral iliac arteriovenous anastomosis for hypertension: targeting mechanical aspects of the circulationCarotid Baroreceptor Stimulation and Arteriovenous Shunts for Resistant HypertensionA comprehensive review of an unmet public health issue: resistant hypertension.Novel strategies for treatment of resistant hypertension.Treatment resistant hypertension--investigation and conservative managementBaroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.The baroreflex as a long-term controller of arterial pressure.Surgical, interventional, and device innovations in the management of hypertensionBaroreflex activation: from mechanisms to therapy for cardiovascular disease.Global- and renal-specific sympathoinhibition in aldosterone hypertensionCan physiology zap therapeutic sweet spots in hypertension?Acute Response to Unilateral Unipolar Electrical Carotid Sinus Stimulation in Patients With Resistant Arterial Hypertension.Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial.Short and Long-Term Effect of Carotid Artery Stenting on Arterial Blood Pressure Measured through Ambulatory Blood Pressure Monitoring.Baroreflex activation therapy in hypertension.The baroreceptor as a therapeutic target for heart failure.Novel and nonpharmacologic approaches to cardio-protection in hypertension.Baroreflex activation therapy for patients with drug-resistant hypertension.Invasive treatment of resistant hypertension: present and future.Carotid baroreceptor stimulation: a potential solution for resistant hypertensionBaroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction.Renal Denervation in Heart Failure.The Baroreflex in Hypertension.Drug therapy for the patient with resistant hypertension.Vagal modulation of hypertension.Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.The Role of Central Nervous System Mechanisms in Resistant Hypertension.Carotid baroreflex activation therapy for resistant hypertension.Electrical carotid sinus stimulation: chances and challenges in the management of treatment resistant arterial hypertension.Autonomic Modulation in Heart Failure: Ready for Prime Time?Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.Device-Based Approaches for the Treatment of Arterial Hypertension.Present and Future of Interventional Treatment of Resistant Hypertension.Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies.Interventional procedures and future drug therapy for hypertension.Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights.Interventional therapy for hypertension: Back on track again?Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?
P2860
Q26745518-05D810EA-D559-4C4E-9F42-718493124D90Q26801336-9AAB5E17-92F7-4BBF-8007-E3408FBC09F2Q28067497-A23C6B54-36D2-4BA0-BB15-AF2B9A0D1200Q30235310-724B8EBA-2F97-48C6-9C7A-4474D1423A17Q33873525-0E3FE71E-2073-4A03-9342-4BF519C42DA5Q33892370-8B6A0BA1-41FA-48B8-AD06-14B511061796Q34477958-02A65447-5821-4DBE-A753-3EE8897EB813Q34543021-896B7812-A298-415E-A5FA-F4E93776DA60Q35138352-335DEE30-743C-4997-84C3-AEECB7063062Q35141548-4E712333-C4C1-42F5-809B-018154E81306Q35190670-D63923F5-0C90-4270-A77D-5096F366A5C0Q35611525-023D79E1-E724-450F-B19B-33F87D19C39BQ36403685-1782804D-3576-4922-A736-3E9E93167D1DQ36638767-A4C7FE8D-497C-497D-B558-128187A2844DQ36742519-9CEB6D64-96F9-451C-8E63-212BEECB9D21Q36946118-E7C766CF-97E7-45D6-9CC6-5C80CC856450Q38183248-49029123-7DB8-44CE-8578-442B98ABDB08Q38190492-3403A0EC-1721-425B-9E07-E8E5842748FCQ38196355-B8F761BC-6A40-438F-9742-7160A1199CB8Q38228854-CFC0BE7A-A17D-40A2-81E0-5492DB2F488DQ38245560-894279D4-D461-4C3F-B125-38FB0460632AQ38246015-849A6784-9D53-4325-ACF4-91E609FEE7C5Q38266330-502CA85E-996C-48F2-BC6E-6D2736D6F627Q38371168-0ED86FE5-D285-43FF-A5D8-C6AD9A8483EBQ38371176-6E3366C4-AFD4-4D49-9D13-7B06B9C44CAEQ38373858-85C35656-C9AF-4C90-8D6C-AAB2B1CD65A3Q38385748-F2F990D5-C2C0-4B75-8D90-B8C466E62702Q38392598-82093728-B392-4E51-AABC-F730C9FB3E9BQ38526496-E27341A4-9A4C-4597-873E-8D5868FD4CE3Q38543355-5DD9ECAB-252A-4DF0-BD86-6F8C8FBF3D9CQ38553738-4B2A3969-78B6-4DF3-B73D-5A859CC8823AQ38588983-49E5AF9D-4B33-41AC-A3B2-ED087CC6109BQ38620423-0795EE2B-228A-4205-92FB-E8850723F97FQ38722982-9DB934A2-36AB-453B-86CF-E65E9F81AE11Q38768579-EE7F2975-ACEA-410C-9303-97C14BAF2E12Q38837789-1E8D7B0F-280C-41CB-B909-30512210167DQ38842624-30AD3FFD-5102-4DCB-9ED6-829DF3009DE6Q38849638-9C460013-034C-4B02-B6E2-A15C993B3C7CQ38860497-45BC286D-A3A3-4BB0-9E27-D59DD74B76ABQ38871976-314D44D6-2D82-4ECD-90A3-E9DD85C00245
P2860
Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Minimally invasive system for ...... s from the Barostim neo trial.
@ast
Minimally invasive system for ...... s from the Barostim neo trial.
@en
Minimally invasive system for ...... s from the Barostim neo trial.
@nl
type
label
Minimally invasive system for ...... s from the Barostim neo trial.
@ast
Minimally invasive system for ...... s from the Barostim neo trial.
@en
Minimally invasive system for ...... s from the Barostim neo trial.
@nl
prefLabel
Minimally invasive system for ...... s from the Barostim neo trial.
@ast
Minimally invasive system for ...... s from the Barostim neo trial.
@en
Minimally invasive system for ...... s from the Barostim neo trial.
@nl
P2093
P50
P1476
Minimally invasive system for ...... s from the Barostim neo trial.
@en
P2093
Abraham A Kroon
Adam W Cates
Eric G Lovett
Lars Christian Rump
Mathias-Christoph Brandt
Uta C Hoppe
P304
P356
10.1016/J.JASH.2012.04.004
P577
2012-06-12T00:00:00Z